FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151425315> ?p ?o ?g. }

• W2151425315 abstract "CD133 and Nestin, as the markers of cancer stem cells, have recently been reported frequently in the pathogenesis and development of human gliomas. However, the prognostic role of CD133 and Nestin in gliomas still remains controversial. In this study, we aimed to evaluate the association between the expression of CD133 and Nestin and the outcome of glioma patients by conducting a systematic review and meta-analysis. We performed systematically electronic and manual searches through the database of Pubmed and embase (until to December 25, 2014) for titles and abstracts which investigated the relationships between CD133 and Nestin expression and outcome of glioma patients. A systematic review and meta-analysis was executed to generate Pooled hazard ratios (HRs) with 95 % confidence intervals (CIs) for overall survival (OS) and progression-free survival (PFS). A total of 1,490 patients from 32 studies (13 articles) were included in the analysis. 19 studies and 13 studies investigated correlation between CD133 expression or Nestin and survival in gliomas, respectively. Our results showed that high CD133 expression in patients with glioma was associated with poor prognosis in terms of OS (HR 1.69; 95 % CI, 1.16–2.47; P =0.0060) and PFS (HR, 1.64; 95 % CI, 1.12–2.39; P = 0.010). In addition, high Nestin expression were associated with worse OS (HR 1.751; 95 % CI, 1.19–2.58, p = 0.004) but has no significant association with PFS (HR 1.55; 95 % CI, 0.96–2.51, p = 0.074). Even more important, the results of the subgroup meta-analyses show that that high CD133 expression was associated with worse prognosis in terms of OS and PFS in patients with WHO IV glioma but not WHO II-III. On the other hand, Nestin high expression was associated with worse prognosis in terms of OS and PFS in patients with WHO II-III glioma but not WHO IV. High level of CD133 expression trends to correlate with a worse OS and PFS in glioma patients, especially WHO IV gliomas and Nestin high expression trends to correlate with a worse OS in glioma patients especially WHO II–III, revealing both the markers of cancer stem cells may as the potential pathological prognostic markers for glioma patients." @default.
• W2151425315 created "2016-06-24" @default.
• W2151425315 creator A5015936079 @default.
• W2151425315 creator A5028040700 @default.
• W2151425315 creator A5035548891 @default.
• W2151425315 creator A5037954064 @default.
• W2151425315 creator A5056171934 @default.
• W2151425315 date "2015-05-14" @default.
• W2151425315 modified "2023-10-16" @default.
• W2151425315 title "Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis" @default.
• W2151425315 cites W116758555 @default.
• W2151425315 cites W1456958198 @default.
• W2151425315 cites W1938258468 @default.
• W2151425315 cites W1945730797 @default.
• W2151425315 cites W1984645684 @default.
• W2151425315 cites W1986815130 @default.
• W2151425315 cites W1994599132 @default.
• W2151425315 cites W1994603761 @default.
• W2151425315 cites W2005026412 @default.
• W2151425315 cites W2012495753 @default.
• W2151425315 cites W2017736079 @default.
• W2151425315 cites W2031164062 @default.
• W2151425315 cites W2032520688 @default.
• W2151425315 cites W2041216245 @default.
• W2151425315 cites W2046659645 @default.
• W2151425315 cites W2050711634 @default.
• W2151425315 cites W2052057604 @default.
• W2151425315 cites W2086779745 @default.
• W2151425315 cites W2086983721 @default.
• W2151425315 cites W2095253236 @default.
• W2151425315 cites W2102275220 @default.
• W2151425315 cites W2105624032 @default.
• W2151425315 cites W2106105815 @default.
• W2151425315 cites W2107359080 @default.
• W2151425315 cites W2110794693 @default.
• W2151425315 cites W2112932851 @default.
• W2151425315 cites W2116247768 @default.
• W2151425315 cites W2117767331 @default.
• W2151425315 cites W2120816159 @default.
• W2151425315 cites W2145988665 @default.
• W2151425315 cites W2148464370 @default.
• W2151425315 cites W2157747429 @default.
• W2151425315 cites W2167650288 @default.
• W2151425315 cites W2170553105 @default.
• W2151425315 doi "https://doi.org/10.1186/s13046-015-0163-4" @default.
• W2151425315 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4436020" @default.
• W2151425315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25967234" @default.
• W2151425315 hasPublicationYear "2015" @default.
• W2151425315 type Work @default.
• W2151425315 sameAs 2151425315 @default.
• W2151425315 citedByCount "68" @default.
• W2151425315 countsByYear W21514253152016 @default.
• W2151425315 countsByYear W21514253152017 @default.
• W2151425315 countsByYear W21514253152018 @default.
• W2151425315 countsByYear W21514253152019 @default.
• W2151425315 countsByYear W21514253152020 @default.
• W2151425315 countsByYear W21514253152021 @default.
• W2151425315 countsByYear W21514253152022 @default.
• W2151425315 countsByYear W21514253152023 @default.
• W2151425315 crossrefType "journal-article" @default.
• W2151425315 hasAuthorship W2151425315A5015936079 @default.
• W2151425315 hasAuthorship W2151425315A5028040700 @default.
• W2151425315 hasAuthorship W2151425315A5035548891 @default.
• W2151425315 hasAuthorship W2151425315A5037954064 @default.
• W2151425315 hasAuthorship W2151425315A5056171934 @default.
• W2151425315 hasBestOaLocation W21514253151 @default.
• W2151425315 hasConcept C121608353 @default.
• W2151425315 hasConcept C126322002 @default.
• W2151425315 hasConcept C136834591 @default.
• W2151425315 hasConcept C143998085 @default.
• W2151425315 hasConcept C207103383 @default.
• W2151425315 hasConcept C2777738006 @default.
• W2151425315 hasConcept C2778227246 @default.
• W2151425315 hasConcept C28328180 @default.
• W2151425315 hasConcept C44249647 @default.
• W2151425315 hasConcept C502942594 @default.
• W2151425315 hasConcept C54355233 @default.
• W2151425315 hasConcept C55427017 @default.
• W2151425315 hasConcept C71924100 @default.
• W2151425315 hasConcept C86803240 @default.
• W2151425315 hasConcept C95190672 @default.
• W2151425315 hasConceptScore W2151425315C121608353 @default.
• W2151425315 hasConceptScore W2151425315C126322002 @default.
• W2151425315 hasConceptScore W2151425315C136834591 @default.
• W2151425315 hasConceptScore W2151425315C143998085 @default.
• W2151425315 hasConceptScore W2151425315C207103383 @default.
• W2151425315 hasConceptScore W2151425315C2777738006 @default.
• W2151425315 hasConceptScore W2151425315C2778227246 @default.
• W2151425315 hasConceptScore W2151425315C28328180 @default.
• W2151425315 hasConceptScore W2151425315C44249647 @default.
• W2151425315 hasConceptScore W2151425315C502942594 @default.
• W2151425315 hasConceptScore W2151425315C54355233 @default.
• W2151425315 hasConceptScore W2151425315C55427017 @default.
• W2151425315 hasConceptScore W2151425315C71924100 @default.
• W2151425315 hasConceptScore W2151425315C86803240 @default.
• W2151425315 hasConceptScore W2151425315C95190672 @default.
• W2151425315 hasIssue "1" @default.
• W2151425315 hasLocation W21514253151 @default.
• W2151425315 hasLocation W21514253152 @default.
• W2151425315 hasLocation W21514253153 @default.

• next